Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus
- PMID: 13109114
- PMCID: PMC2136340
- DOI: 10.1084/jem.98.6.641
Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus
Abstract
The effects on the antibody content of the population which result from repeated exposure to antigenic variants of influenza viruses have been studied by measuring, with many strains, the antibody content of lots of gamma globulin prepared in different years and the patterns of antibody found in sera collected in 1 year from various age groups. In all samples of gamma globulin collected from 1943 through 1951, high levels of antibody were found with strains of Type A and Type B influenza viruses isolated prior to 1941. The highest levels were found in the more recent collections of gamma globulin. Antibodies to A-prime, and to B strains of 1945 and 1952, were present at low levels in gamma globulin collected prior to the isolation of these viruses. A moderate increase in antibody was observed in the gamma globulin of recent years. The pattern of distribution of antibody by age found with most A-prime strains in serum pools exhibited high levels in infancy and childhood, but after the age of 20, little or no antibody was detected. With Type A strains antibody was usually not observed until the 11th year of age. Thereafter, high levels were present until age 20, when the amount of antibody declines to a moderate and relatively constant level which persists throughout life. Antibody against swine influenza virus did not become detectable until the 29th year. The intermediate antigenic character of a few A-prime isolates was reflected in the antibody pattern obtained with them. Antibody was not found until age 13 with the Lee (1940) strain of Type B influenza virus, but thereafter the level was high. With the type B isolates of 1945 and 1952, antibody became measurable at earlier ages. The present data clearly demonstrate that in the early years of life the range of the antibody spectrum is narrow, and that it becomes progressively broader in later life. A striking correlation was found between what is known of the periods of prevalence of certain strains of influenza viruses and the age of the people in whom strain-specific antibodies are currently found. It has been observed that the age at which antibodies to certain strains are first detectable has progressively advanced with the passage of time. From these data the following immunologic thesis is formulated. The antibody which is acquired during the initial infections of childhood is of limited scope and reflects the dominant antigens of the prevailing strains. The immunity conferred by the initial experiences with influenza is also limited. Successive experiences later in life with viruses of related but differing antigenic make-up result in a composite of antibody which is oriented toward a larger number of the common antigens which comprise influenza virus. These experiences confer a broader immunity which limits infection with, and antibody response to, the more recently encountered strains. The antibody-forming mechanisms appear to be oriented by the initial infections of childhood so that exposures later in life to antigenically related strains result in a progressive reinforcement of the primary antibody. The highest cumulative antibody levels detectable in a particular age group tend, therefore, to reflect the dominant antigens of the virus responsible for the childhood infections of that group. Hence the pattern of antibody distribution determined currently in different age groups provides a serologic recapitulation of past infection with antigenic variants of influenza viruses.
Similar articles
-
A serologic recapitulation of past experiences with influenza A; antibody response to monovalent vaccine.J Exp Med. 1956 Jul 1;104(1):85-97. doi: 10.1084/jem.104.1.85. J Exp Med. 1956. PMID: 13332182 Free PMC article.
-
Influenza antibodies in the population of the USA; an epidemiological investigation.Bull World Health Organ. 1953;8(5-6):613-31. Bull World Health Organ. 1953. PMID: 13094497 Free PMC article.
-
Characterization of influenza antibodies by serum absorption.J Exp Med. 1956 Aug 1;104(2):199-209. doi: 10.1084/jem.104.2.199. J Exp Med. 1956. PMID: 13345965 Free PMC article.
-
Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.Drugs R D. 2003;4(5):312-9. doi: 10.2165/00126839-200304050-00007. Drugs R D. 2003. PMID: 12952502 Review.
-
Virus-specific T cells as correlate of (cross-)protective immunity against influenza.Vaccine. 2015 Jan 15;33(4):500-6. doi: 10.1016/j.vaccine.2014.11.054. Epub 2014 Dec 9. Vaccine. 2015. PMID: 25498210 Review.
Cited by
-
Influenza virus immune imprinting dictates the clinical outcomes in ferrets challenged with highly pathogenic avian influenza virus H5N1.Front Vet Sci. 2023 Dec 19;10:1286758. doi: 10.3389/fvets.2023.1286758. eCollection 2023. Front Vet Sci. 2023. PMID: 38170075 Free PMC article.
-
Cross-reactive antibodies induced by a monovalent influenza B virus vaccine.J Clin Microbiol. 1991 Jul;29(7):1530-2. doi: 10.1128/jcm.29.7.1530-1532.1991. J Clin Microbiol. 1991. PMID: 1885750 Free PMC article.
-
Lymphocyte blastogenic responses to influenza virus antigens after influenza infection and vaccination in humans.Infect Immun. 1978 Mar;19(3):867-74. doi: 10.1128/iai.19.3.867-874.1978. Infect Immun. 1978. PMID: 640733 Free PMC article.
-
Disquisitions of Original Antigenic Sin. I. Evidence in man.J Exp Med. 1966 Sep 1;124(3):331-45. doi: 10.1084/jem.124.3.331. J Exp Med. 1966. PMID: 5922742 Free PMC article.
-
Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus.Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):3166-71. doi: 10.1073/pnas.0308391100. Epub 2004 Feb 12. Proc Natl Acad Sci U S A. 2004. PMID: 14963236 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous